ArticleJournal of surgical case reports2026
Robotic uterine transposition and reposition in a patient with rectal cancer: complete case report and surgical perspective.
Article in Journal of surgical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Uterine transposition (UT) is an emerging fertility-preserving technique for women requiring pelvic radiation. We report our first complete robotic UT followed by successful robotic uterovaginal anastomosis (uterine reposition, UR) in the multimodal treatment of rectal adenocarcinoma. A 29-year-old nulligravid woman with locally advanced rectal cancer underwent robotic UT in February 2024 prior to neoadjuvant chemoradiation. The uterus and adnexa were transposed to the upper abdomen with preservation of vascular supply, perfusion confirmed by fluorescence angiography, and a temporary neocervical canal created at the umbilicus. In March 2025, robotic UR was performed concurrently with abdominoperineal resection and end colostomy. Surgery was completed without intraoperative complications. Pathology revealed mucinous adenocarcinoma with one positive lymph node and negative margins. Despite later systemic recurrence, the uterus remained viable and menstruation resumed through the native cervix. This case demonstrates the feasibility of robotic UT and UR for fertility preservation in complex oncologic care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.